Detection and localisation of hesitant steps in people with Alzheimer's disease navigating routes of varying complexity. by McCarthy, Ian et al.
McCarthy, Ian; Suzuki, Tatsuto; Holloway, Catherine; Poole, Teresa;
Frost, Chris; Carton, Amelia; Tyler, Nick; Crutch, Sebastian; Yong,
Keir (2019) Detection and Localisation of Hesitant Steps in People
with Alzheimer’s Disease Navigating Routes of Varying Complexity.
Health Technology Letters. ISSN 2053-3713 (In Press)
Downloaded from: http://researchonline.lshtm.ac.uk/4650908/
DOI:
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
Healthcare Technology
Letters
Detection and Localisation of Hesitant Steps in
People with Alzheimer's Disease Navigating
Routes of Varying Complexity
HTL-2018-5034.R1 | Letter
Submitted on:  12-06-2018
Submitted by:  Ian McCarthy, Tatsuto Suzuki, Catherine Holloway, Teresa Poole, Chris Frost, Amelia Carton, Nick Tyler,
Sebastian Crutch, Keir Yong
Keywords:  INERTIAL SENSOR, NAVIGATION SYSTEM, ALZHEIMER'S DISEASE, MOBILITY
ReView by River Valley Technologies Healthcare Technology Letters
2018/12/19 12:59:31 IET Review Copy Only 1
 
     
 
 
 
1 
 
 
Detection and Localization of Hesitant Steps in People with Alzheimer’s Disease 
Navigating Routes of Varying Complexity  
 
I.McCarthy1, T.Suzuki1, C.Holloway2, T.Poole3,4, C.Frost3,4, A.Carton4, N.Tyler1, S.Crutch4, K.Yong4 
 
1 Pedestrian Accessibility and Movement Environment Laboratory, Department of Civil Environmental and Geomatic Engineering, 
University College London, N19 5UN, UK.  
2 UCL Interaction Centre, Department of Computer Science, University College London, London  
3Department of Medical Statistics, Faculty of Epidemiology and Public Health, London School of Hygiene & Tropical Medicine, 
London 
4Dementia Research Centre, Institute of Neurology, University College London, London, UK.  
E-mail: i.mccarthy@ucl.ac.uk 
 
People with Alzheimer’s disease (AD) have characteristic problems navigating everyday environments. While patients may exhibit abnormal gait 
parameters, adaptive gait irregularities when navigating environments are little explored or understood. The aim of this study was to assess adaptive 
locomotor responses of AD subjects in a complex environment requiring spatial navigation. A controlled environment of three corridors was set up: 
straight (I), U-shaped (U), and dog-leg (S). Participants were asked to walk along corridors as part of a counterbalanced repeated-measures design. 
Three groups were studied: 11 people with posterior cortical atrophy (PCA), 10 with typical Alzheimer’s disease (tAD) and 13 controls. Spatio-
temporal gait parameters and position within the corridors were monitored with shoe-mounted inertial measurement units (IMUs). Hesitant steps 
were identified from statistical analysis of the distribution of step time data. Walking paths were generated from position data calculated by double 
integration of IMU acceleration. People with PCA and tAD had similar gait characteristics, having shorter steps and longer step times than controls. 
Hesitant steps tended to be clustered within certain regions of the walking paths. IMUs enabled identification of key gait characteristics in this 
clinical population (step time, length and step hesitancy) and environmental conditions (route complexity) modifying their expression. 
1. Introduction: Early and common symptoms of Alzheimer’s 
disease are problems in spatial navigation, greatly undermining 
autonomy. While such problems are often associated with deficits in 
memory and planning, the role of dementia-related visual processing 
impairments in limiting navigation, particularly in familiar 
environments, is often under-recognised [1]. In typical Alzheimer’s 
disease (tAD), initial pathological changes in medial temporal regions 
particularly associated with episodic and spatial memory ultimately 
progress to posterior cortical regions, including those supporting 
visuospatial processing [2]. A neurodegenerative syndrome offering 
important insights into dementia-related visual impairment is posterior 
cortical atrophy (PCA) [3]. While PCA is most commonly caused by 
Alzheimer’s disease, in contrast to tAD, PCA patients demonstrate 
relatively well-preserved memory, particularly in early disease stages, 
but exhibit a range of complex visual deficits and environmental 
disorientation [4, 5, 6, 7]. 
Gait function has also been shown to be impaired in dementia.  
Indeed, it has even been suggested that gait could be used as a 
biomarker of cognitive impairment and dementia syndromes [8]. 
Changes in step length, step time and walking speed have been 
observed in people with both cognitive impairment and dementia [9], 
and gait changes appear to be related to the stage of the disease: [10, 
11, 12]. Although a basic gait laboratory setting has been used to 
assess gait in tAD while also performing a cognitive task [13, 14], this 
does not replicate the daily navigational challenges of people with 
visual and/or cognitive problems. Perceptual factors (e.g. lighting, 
clutter) may have a disproportionate effect on functional performance 
in tAD, but situations that replicate these conditions are difficult to set 
up in a standard gait laboratory. Creating environments with walls and 
confined spaces makes it very difficult to use standard opto-electronic 
motion capture systems, which require a line-of-sight view from the 
motion detection camera to the subject.  
Sensors attached directly to the participants would, in principle, 
enable assessment of spatio-temporal gait characteristics under any 
environment. Inertial measurement units (IMUs) comprise systems of 
orthogonal tri-axial accelerometers, gyroscopes and sometimes 
magnetometers, and can provide a portable means of measuring 
movement. IMUs have been used in studies of gait in healthy ageing 
[15, 16]. Their use in the assessment of gait in Parkinson’s disease and 
dementia has recently been described [17]. IMUs can also provide an 
infrastructureless means of tracking the position of first responders 
within buildings in emergency situations [18], and for tracking people 
outdoors when GPS signals are not available [19]. IMUs therefore 
have the potential of being able to measure simultaneously both 
spatio-temporal characteristics of participants’ gait and their location. 
This study is part of a more general investigation of gait and spatial 
navigation in people with dementia in a controlled real-world 
environment. It is proposed that people with PCA and tAD would 
exhibit inefficient adaptation of gait in response to local environments 
(corridor turns). In this present study we investigate the feasibility of 
using IMUs to detect and localize hesitant behavior. 
 
2. Methods:  
Testing Environment. The main platform of PAMELA consisted of 54 
(9 x 6) configurable 1200mm × 1200mm modules. Wood boards of 
55mm in thickness were put on top of the concrete modules and then 
covered with dark-blue domestic carpet. The entire area of floor was 
gap-free and levelled. The platform was configured to provide three 
corridors with 2.1m high walls using free-standing wooden panels 
(2100mm height, 1200mm width, 42mm thickness) as walls. Walls 
were of good contrast to the floor carpet, consistent with residential 
design recommendations for individuals with sight loss and dementia 
[20]. The three corridors comprised: a 6m straight (I) corridor, a 8.4 m 
U-shaped corridor with two 90o turns in the same direction, and a 
8.4m “dog-leg” (S) corridor with two 90o turns in opposite directions. 
These are illustrated schematically in Figure 1, along with an 
overhead image of the set-up. The average ground illuminance was set 
at 190 lux, which is a typical indoor lighting level for homes.  
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Figure 1. Schematic illustration of the corridor arrangement (top), and fish-
eye camera view of PAMELA platform showing the boxes and panels used to 
construct the corridors (bottom). The arrangement allowed U- and S-shaped 
corridors to be created by the movement of one panel, marked in red in the 
schematic view. 
 
 
Participants and Procedures. Two groups of dementia patients were 
studied: 11 with PCA (mean age: 64.6 ± 5.6 years; male/female: 5/6; 
height (cm): 168.9 ± 6.5; Mini Mental State Examination (MMSE) 
score: 18.4 ± 5.9), and 10 with tAD (mean age: 66.2 ± 5.0 years; 
male/female: 4/6; height: 167.9 ± 11.8; MMSE: 18.6 ± 4.9). These 
were compared with a control group (n=13, mean age: 64.2 ± 4.1 
years; male/female: 7/6; height: 171.2 ± 12.9); groups were well-
matched on age, height and gender. PCA and tAD patients fulfilled 
consensus criteria for PCA and NIA-AA criteria for tAD respectively. 
Exclusion criteria were a history of other neurological or major 
psychiatric diseases. Patients did not fulfil clinical criteria for 
dementia with Lewy bodies, Parkinson’s disease, corticobasal 
degeneration or prion disease or exhibit associated clinical features 
(e.g. early visual hallucinations, parkinsonism, ataxia). Each 
participant had IMUs attached to each heel, as described above. 
Participants were asked to “keep walking until you reach the end of 
the corridor”. The start of each trial was verbally signaled by the 
experimenter (“Start”) preceded by counting down from three. Trials 
ended when participants crossed the finishing line of the route (0.6m 
from the end of each corridor). Participants walked down each of 
three route shapes in both directions (outward and return), resulting in 
a total of 6 trials for each participant. Data for the outward direction in  
 
one trial for one participant were rejected for technical reasons. Order 
of route and direction conditions were counterbalanced between 
participants to control for order effects. Ethical approval for the study 
was provided by the National Research Ethics Service London-Queen 
Square ethics committee and written informed consent was obtained 
from all participants. 
 
Assessment of Movement with Inertial Measurement Units. The 
measurement technique has been outlined previously [21]. IMUs 
(Xsens, The Netherlands) were attached to the heel of each foot. Local 
accelerations were converted to the laboratory frame with a 3D 
rotation matrix, using orthogonal acceleration data combined with 
roll, pitch and yaw values provided by the IMU software. Stance 
phases for each foot were identified from resultant acceleration values 
below 1 m/s2. Initial calculations of foot velocity were performed by 
integration of the orthogonal acceleration data. Sensor drift was then 
corrected using zero velocity updates applied to identified stance 
phases., and the corrected velocity was integrated to provide 
displacement in three orthogonal directions [18, 19]. A 2D rotation 
was then applied to the walking paths to align them with the 
laboratory orientation. Step length and step time were computed for 
each step during these walking tasks, together with position on the 
platform. Outlier steps were identified using a statistical method 
outlined below. For a summary of stages in outlier identification and 
localization, see Figure 2. 
 
Statistical Analyses. All statistical analyses were carried out using 
Stata V.14. Descriptive statistics for step times and step lengths were 
calculated by group for each of the corridor configurations (I-, U- and 
S-shaped), expressed as the mean and standard deviation of the within 
person means (ignoring journey direction).  
To identify and remove outlying long step times (i.e. hesitant 
steps), an iterative procedure was used as follows. For each of the 
“group by route” combinations, a three-level linear mixed model that 
included random person and (within person) journey effects was fitted 
in order to allow for correlations between repeated measurements 
from the same subject, and between measurements for the same 
journey.  Outliers with long step times were defined as observations 
with a standardized residual greater than 3; these outliers were 
dropped and the model refitted and outlier removal repeated until no 
further outliers were identified. A similar process was used to identify 
outlier short step lengths (i.e. steps covering a short distance), defined 
as those with a standardized residual less than –3.  
Having removed outliers, subsequent comparisons of person-
specific means by group and by route shape were performed as 
follows. First, for a given route shape (I-, U- or S), comparisons 
between participant groups (PCA, tAD, controls) were made: i) for 
mean step times using a generalized least squares linear regression 
that allowed for the apparent different variability of groups; and ii) for 
mean step lengths using an ordinary least squares linear regression. In 
each case only if a global test for a difference was statistically 
significant were pairwise comparisons made. Second, for a given 
participant group (PCA, tAD, controls), comparison across route 
shapes (I-, U- or S-corridor) were made: iii) for mean step times and 
iv) mean step lengths, using Wilcoxon matched-pairs signed-ranks 
tests. For all study analyses, statistical significance was set at p<0.05 
(two-tailed test). There was no adjustment for multiple testing. 
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Figure 2. Flow diagram outlining computational stages in detecting 
and locating hesitant steps, starting from the box at the top left. 
 
 
3. Results:  
Spatio-temporal gait parameters. Descriptive statistics of the spatio-
temporal parameters of gait, excluding outliers as defined in terms of 
standardized residuals described in “Statistical analysis” above, are  
shown in Table 1. Within the trials, there was some marked variability 
of step time and step length, particularly for the U- and S-corridors. 
This is illustrated in Figure 3 for step time, in which individual step 
times for each participant are plotted; there are clearly a small number 
of outlier values. A total of 37 out of 2,395 step times (1.5%) were 
considered outliers, 12/626 (1.9%), 17/863 (2.0%) and 8/906 (0.9%) 
for the straight, U- and S-shaped corridors respectively (see Table 2 
for group level outlier numbers for step times and lengths). Outliers 
were not included in subsequent statistical analysis of group and route 
comparisons. 
Comparison between groups for each individual route shape 
showed that mean step time was significantly longer and mean step 
length significantly shorter when comparing the PCA and tAD groups 
with controls (p = 0.001 or less), but no significant differences were 
observed when comparing PCA and tAD. When making comparisons 
between routes for each participant group, step length when walking 
along the straight corridor was significantly longer than step length 
walking along the other corridors for all three groups (p=0.013 or 
less), but differences in step times were small and predominantly did 
not show any statistically significant differences (see Table 1). 
 
Paths of routes during walking. Paths for all participants in the three 
groups are shown in Figure 4, for walking in both the U- and S-
shaped corridors. Observed qualitative differences between paths 
include sharper right-angled turns for patient groups compared to 
controls, seen particularly at the first corner. This type of behavior is 
illustrated in two attached videos, showing animations of the walking 
paths for one control participant and one person with PCA, walking 
along the U-shaped corridor. 
 
Hesitant Steps. Also shown in Figure 4 are the positions of step times 
identified as outliers. Clearly, there are some large step times of 
greater than 2 seconds for the U-shaped corridor between 2 and 4 
metres of the individual patient trajectories. 8/139 step times in this  
 
 
Step Time (s) 
 
 
I-ROUTE U-ROUTE S-ROUTE 
Step time 
comparison  
Controls 
0.576 
(0.052) 
0.588 
(0.053) 
0.585 
(0.060) 
U vs I: p=0.064 
S vs I: p=0.184 
S vs U: p=0.780 
PCA 
0.691* 
(0.075) 
0.743* 
(0.090) 
0.724* 
(0.076) 
U vs I: p=0.016 
S vs I: p=0.062 
S vs U: p=0.182 
tAD 
0.730* 
(0.122) 
0.803* 
(0.197) 
0.759* 
(0.153) 
U vs I:  p=0.241 
S vs I:  p=0.647 
S vs U: p=0.386 
 
 
Step Length (m) 
 
 
I-ROUTE U-ROUTE S-ROUTE 
Step length 
comparison 
Controls 
0.738 
(0.128) 
0.689 
(0.132) 
0.688 
(0.127) 
U vs I: p=0.003 
S vs I: p=0.005 
S vs U: p=0.861 
PCA 
0.503* 
(0.101) 
0.405* 
(0.122) 
0.430* 
(0.111) 
U vs I: p=0.003 
S vs I: p=0.003 
S vs U: p=0.131 
tAD 
0.548* 
(0.073) 
0.476* 
(0.143) 
0.482* 
(0.104) 
U vs I: p=0.013 
S vs I: p=0.013 
S vs U: p=0.879 
 
Table 1. Mean (standard deviation) of the observed person-specific 
mean step times (top) and step lengths (bottom) for the three 
participant groups walking under each of the three route conditions, 
excluding outlier values. For each participant group, p-values are for 
Wilcoxon matched-pairs signed-rank tests comparing route shapes. 
Asterisks denote group differences (vs controls: *p≤.001). 
 
 
 
 Step Time 
I-ROUTE U-ROUTE S-ROUTE 
Control 8/191 
(4.2%) 
2/237 
(0.8%) 
1/258 
(0.4%) 
PCA 2/238 
(0.8%) 
9/354 
(2.54%) 
5/368 
(1.4%) 
tAD 2/197 
(1.0%) 
6/272 
(2.2%) 
2/280 
(0.7%) 
 
 Step Length 
I-ROUTE U-ROUTE S-ROUTE 
Control 4/191 
(2.1%) 
0/237  
(0%) 
1/258 
(0.4%) 
PCA 5/238 
(2.1%) 
0/354  
(0%) 
0/368  
(0%) 
tAD 7/197 
(3.6%) 
0/272  
(0%) 
0/280  
(0%) 
 
Table 2. Number of outliers/total observations (%) by participant 
group and route shape for step times (top) and step lengths (bottom). 
 
ReView by River Valley Technologies Healthcare Technology Letters
2018/12/19 12:59:31 IET Review Copy Only 4
 
     
 
 
 
4 
  
 
 
Figure 3. Scatter plots of step time for corridor conditions by participant group. Plots show individual step times per participant per trial A) including and B) 
excluding outliers (step times greater than 3 standardised residuals mean for each participant) 
 
. 
region were outliers for the PCA group, and 6/108 step times were 
outliers for the tAD group. For the S-shaped corridor, 3/111 step times 
were outliers for the PCA group in the region from 4 to 6 metres; for 
the tAD group there were no outlying step times in this section. For 
the I-shaped corridor there were very few outliers except for controls 
where 7/62 step times in the 0 to 2 metre region were outliers, all of 
which occurred very early in the patient route. 
 
4. Discussion:  
Rigorous investigation of accessibility and mobility issues in people 
with physical and/or cognitive impairment should ideally be 
performed in environments that replicate the “real-world” situations 
groups of participants which are known to have problems in such 
situations. Such environments are difficult to set up in conventional 
motion capture laboratories using opto-electronic motion capture 
equipment. In the present study, we have been able to create a simple 
In the present study, we have been able to create a simple scenario 
involving participants with different presentations of dementia 
navigating routes. Findings suggest that IMUs can be used in such 
environments to provide information on clinically relevant behaviour. 
Gait was similar in both PCA and tAD groups. Even excluding 
outliers, participants with dementia had shorter steps lengths and 
longer step times compared with controls. Differences in step times 
and length were observed when comparing different routes, in 
agreement with previous observations for adaptive gait in people with 
Alzheimer’s disease [23]. Although measures of gait variability in AD 
are frequently reported in the literature, the overall lengths of the 
paths walked by the participants were rather shorter than advised for a 
statistical description of the distribution of step time and step length 
data [24]. However, the aim of this study was to understand how 
deviations in step time and length related to specific locations within 
the tasks. As such, it was far more useful to identify outlier steps, 
which could then be considered indicators of hesitation. The criterion 
for defining an outlier step for an individual was based on that 
individual’s step data, rather than using one fixed absolute value of 
step time as a threshold. In this way, disproportionately increased step 
times could be reliably identified and located for each individual. 
The data show a consistent pattern of hesitation, determined by step 
time, for some dementia patients during the tasks. The clustering of 
hesitant steps at particular locations indicates that the approach of 
outlier detection may be more informative, as compared to a simple 
description of gait variability. Although it was possible to identify the 
location of hesitant steps, it is still uncertain what specific 
characteristics of that location induced this behavior. The assessment 
of visually salient features within the visual field at these locations, 
combined with investigation of eye fixations could further identify 
problematic environmental characteristics, leading to the potential for 
design modifications in the built environment to improve mobility. 
     Tracking the position of the participants used the principle of dead 
reckoning, i.e. estimation of position from knowledge of initial 
position and subsequent movement from that position. However, 
during testing it was difficult to position some participants on a 
precisely defined mark at the start of each trial, and so this was not 
included in the protocol. The starting position varied within a square 
of approximately 60cm, and this position was not recorded. The plots 
in Figure 4 therefore show all participants starting from the same 
point (0,0). This difference between actual and ideal starting position 
explains some of the variation in the final positions for the complex 
corridors tasks. All paths are within the range of permissible paths 
allowed by the physical constraints of the walls. Although effects of 
sensor drift on walking paths are possible, we have taken steps to 
mitigate this using zero velocity update. A guide to the amount of drift 
in x- and y-positions can be obtained by assessment of drift in the 
vertical (z) direction, which was typically of the order of 5 cm when 
comparing the start and end of each trial. 
Some of the people with dementia took abrupt turns at the corners. 
The primary importance of visuomotor control in anticipatory actions 
for adaptive walking is recognized [25, 26]. Controls were clearly able 
to anticipate the corners and walked with an efficient smooth path 
around the corners, but some participants in the dementia groups did 
not demonstrate the same anticipation. Either they were not able to 
efficiently interpret or act on the visual information, due to low visual 
orientation or visuomotor/visual processing impairments, or were 
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Figure 4. Calculated trajectories for the right foot around the U- (left two columns) and S-shaped (right two columns) corridors, for control (top row), PCA (middle 
row) and tAD (bottom row), walking in one direction and then returning in the opposite direction (the arrow indicates the direction of walk). The origin was set as 
the same for all participants, though in practice this was not necessarily the case. Crosses indicate the positions of hesitant steps, defined as a step time greater 
than 3 standardised residuals from the mean for each participant. 
 
 
unable to predict layouts of routes due to diminished topographical 
processing, spatial memory and/or executive function [22]. Future 
investigations might explore the relationship between gait dynamics, 
spatial memory and route learning abilities. Future investigations 
might explore the relationship between gait processing, spatial 
memory and/or executive function. Future dynamics, spatial memory 
and route learning abilities. Multi-target stepping tests have shown 
that young people fixate about three steps ahead, but that older adults 
at risk of falling fixate around the immediate target [27]. Visual cues 
at specific locations may potentially improve adaptive response and 
functional performance  
It was not possible to use conventional techniques for tracking 
participants and monitoring gait, because the walls blocked any line-
of-sight observation of participants. Overall, a total of 2,395 steps 
were processed. In order to make data processing feasible for such a 
number of steps, a batch processing approach was used, in which a 
standard threshold of resultant acceleration was used to define swing 
and stance phases of gait. Although this may impact on the sensitivity 
and specificity of the processing of step data, the technique has the 
potential to be used extensively in the assessment of mobility in 
complex environments, where the portability of the technique and lack 
of constraints on the physical infrastructure are significant advantages. 
It is therefore particularly beneficial to be able to use standardized 
algorithms to process step data. In the context of research into 
dementia friendly environments, the effects of perceptual 
environmental variables, such as lighting, visual cues and clutter on 
patient navigation can be evaluated in a variety of scenarios [22]. 
The advantage of using the current sensor-based system to track 
position and measure gait is that no specific infrastructure is required 
to perform the measurements. The sensors are portable, and no 
modification of the local environment is necessary. Within the context 
of Alzheimer’s disease research, participant spatio-temporal data 
collection may be facilitated in environments such as day centre or 
residential care settings. More generally, the technique is applicable to 
study mobility in the built environment for people with both physical 
and cognitive impairment. In summary, this work demonstrates the 
feasibility of IMUs to be used to perform pedestrian navigation and 
analysis of spatio-temporal characteristics of gait simultaneously. 
Both patient groups differed from controls but PCA and tAD patients 
shared similar spatio-temporal gait characteristics. Identification of 
outlier step times from standardized residuals allowed the 
identification of locations where participants tended to hesitate.  
 
5. Conclusion: 
It was feasible to use IMU sensor technology to assess how people 
with Alzheimer’s disease responded to environmental factors (route 
complexity) when navigating simulated indoor environments. We 
consider that such an approach is generally applicable to the 
investigation of mobility in the built environment. 
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